Literature DB >> 34257161

Prognostic value of fatty acid metabolism-related genes in patients with hepatocellular carcinoma.

Dongsheng He1, Lifang Cai1, Weiming Huang1, Qingqing Weng1, Xi Lin1, Mengxing You1, Shengyin Liao1.   

Abstract

The deregulation of fatty acid metabolism plays a crucial role in cancer. However, the prognostic value of genes involved in the metabolism in hepatocellular carcinoma (HCC) remains largely unknown. We first constructed a multi-fatty acid metabolic gene prognostic model of HCC based on The Cancer Genome Atlas (TCGA) and further validated it using the International Cancer Genome Consortium (ICGC) database. The model was integrated with the clinical parameters, and a nomogram was built and weighted. Moreover, immune cell infiltration of the tumor microenvironment was investigated. A prognostic model was constructed using 6 selected fatty acid metabolism-related genes, and HCC patients were divided into high- and low-risk groups. Receiver operating characteristic curve (ROC) analysis, principal component analysis (PCA), and t-distributed stochastic neighbor embedding (t-SNE) analysis showed the optimal performance of the model. The concordance index (C-index), ROC curve, calibration plot and decision curve analysis (DCA) all confirmed the satisfactory predictive capacity of the nomogram. The analysis of immune cell infiltration in HCC patients revealed a correlation with different risk levels. Our findings indicate that a prognostic model based on fatty acid metabolism-related genes has superior predictive capacities, which provides the possibility for further improving the individualized treatment of patients with HCC.

Entities:  

Keywords:  ICGC; TCGA; fatty acid metabolism; hepatocellular carcinoma; prognosis

Year:  2021        PMID: 34257161     DOI: 10.18632/aging.203288

Source DB:  PubMed          Journal:  Aging (Albany NY)        ISSN: 1945-4589            Impact factor:   5.682


  8 in total

1.  A Potential Fatty Acid Metabolism-Related Gene Signature for Prognosis in Clear Cell Renal Cell Carcinoma.

Authors:  He Zhang; Di Zhang; Xiaopeng Hu
Journal:  Cancers (Basel)       Date:  2022-10-09       Impact factor: 6.575

2.  Identification of a Prognostic Model Based on Fatty Acid Metabolism-Related Genes of Head and Neck Squamous Cell Carcinoma.

Authors:  Peiyu Du; Yue Chai; Shimin Zong; Jianxin Yue; Hongjun Xiao
Journal:  Front Genet       Date:  2022-06-30       Impact factor: 4.772

3.  N7-Methylguanosine Regulatory Genes Profoundly Affect the Prognosis, Progression, and Antitumor Immune Response of Hepatocellular Carcinoma.

Authors:  Kexiang Zhou; Jiaqun Yang; Xiaoyan Li; Wei Xiong; Pengbin Zhang; Xuqing Zhang
Journal:  Front Surg       Date:  2022-06-16

4.  Characteristics of Fatty Acid Metabolism in Lung Adenocarcinoma to Guide Clinical Treatment.

Authors:  Dejing Huang; Enyu Tang; Tianze Zhang; Guangquan Xu
Journal:  Front Immunol       Date:  2022-07-01       Impact factor: 8.786

5.  Bioinformatics analysis and experimental verification of the prognostic and biological significance mediated by fatty acid metabolism related genes for hepatocellular carcinoma.

Authors:  Xiao-Ren Zhu; Jia-Qi Zhu; Yu-Fei Chen; Yuan-Yuan Liu; Jing-Jing Lu; Jun Sun; Shi-Qing Peng; Min-Bin Chen; Yi-Ping Du
Journal:  Front Oncol       Date:  2022-08-02       Impact factor: 5.738

6.  Mitochondrial Aldehyde Dehydrogenase 2 Represents a Potential Biomarker of Biochemical Recurrence in Prostate Cancer Patients.

Authors:  Dechao Feng; Weizhen Zhu; Jia You; Xu Shi; Ping Han; Wuran Wei; Qiang Wei; Lu Yang
Journal:  Molecules       Date:  2022-09-15       Impact factor: 4.927

7.  Identification of subtypes of clear cell renal cell carcinoma and construction of a prognostic model based on fatty acid metabolism genes.

Authors:  Shiwen Nie; Youlong Huili; Anliang Yao; Jian Liu; Yong Wang; Lei Wang; Liguo Zhang; Shaosan Kang; Fenghong Cao
Journal:  Front Genet       Date:  2022-09-16       Impact factor: 4.772

8.  Characterization of cancer-related fibroblasts (CAF) in hepatocellular carcinoma and construction of CAF-based risk signature based on single-cell RNA-seq and bulk RNA-seq data.

Authors:  Lianghe Yu; Ningjia Shen; Yan Shi; Xintong Shi; Xiaohui Fu; Shuang Li; Bin Zhu; Wenlong Yu; Yongjie Zhang
Journal:  Front Immunol       Date:  2022-09-23       Impact factor: 8.786

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.